BioLineRx Ltd. (BLRX)

BioLineRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.84	4.26	10.59	12.99	16.83	5.3
Short-Term Investments	20.34	38.74	40.5	44.15	5.76	22.19
Cash & Short-Term Investments	29.17	42.99	51.08	57.14	22.59	27.49
Cash Growth	12.34%	-15.83%	-10.59%	152.96%	-17.83%	-8.83%
Accounts Receivable	3.61	0.36	-	-	-	-
Other Receivables	0.35	0.83	0.72	0.14	0.14	0.61
Receivables	3.96	1.19	0.72	0.14	0.14	0.61
Inventory	3.54	1.95	-	-	-	-
Prepaid Expenses	1.17	1.05	0.2	0.13	0.15	0.11
Total Current Assets	37.85	47.18	52	57.4	22.88	28.21
Property, Plant & Equipment	1.65	1.89	2.5	2.28	2.7	3.47
Other Intangible Assets	13.25	14.85	21.89	21.7	21.71	21.89
Total Assets	52.74	63.93	76.38	81.39	47.29	53.57
Accounts Payable	4.63	10.87	6.97	5.57	5.92	7.79
Accrued Expenses	-	3.27	1.66	1.23	1.44	1.27
Current Portion of Long-Term Debt	9.82	3.15	1.54	2.76	3.09	2.69
Current Portion of Leases	0.52	0.53	0.43	0.17	0.19	0.2
Current Unearned Revenue	2.26	12.96	-	-	-	-
Other Current Liabilities	7.74	0.09	0.08	0	0	0.01
Total Current Liabilities	24.96	30.85	10.68	9.72	10.64	11.97
Long-Term Debt	17.98	6.63	8.63	-	2.74	5.8
Long-Term Leases	1.29	1.29	1.73	1.73	1.66	1.76
Other Long-Term Liabilities	-	11.93	4.51	1.86	10.22	0.66
Total Liabilities	44.24	50.7	25.54	13.3	25.26	20.19
Common Stock	34.43	31.36	27.1	21.07	9.87	4.69
Additional Paid-In Capital	353.01	355.48	338.98	339.35	279.24	265.94
Retained Earnings	-396.64	-390.61	-329.99	-305.04	-277.99	-247.97
Comprehensive Income & Other	17.71	16.99	14.76	12.72	10.91	10.72
Shareholders' Equity	8.51	13.22	50.84	68.09	22.03	33.38
Total Liabilities & Equity	52.74	63.93	76.38	81.39	47.29	53.57
Total Debt	29.61	11.59	12.32	4.65	7.68	10.46
Net Cash (Debt)	-0.44	31.4	38.76	52.48	14.9	17.03
Net Cash Growth	-	-18.98%	-26.15%	252.17%	-12.51%	-20.47%
Net Cash Per Share	-0.00	0.03	0.05	0.08	0.06	0.12
Filing Date Shares Outstanding	1,200	1,087	922.96	715.16	349.17	171.27
Total Common Shares Outstanding	1,200	1,087	922.96	715.16	349.17	171.27
Working Capital	12.89	16.33	41.32	47.69	12.24	16.24
Book Value Per Share	0.01	0.01	0.06	0.10	0.06	0.19
Tangible Book Value	-4.74	-1.63	28.96	46.38	0.32	11.49
Tangible Book Value Per Share	-0.00	-0.00	0.03	0.06	0.00	0.07
Machinery	-	2.93	2.81	2.66	2.56	2.56
Leasehold Improvements	-	2.04	2.04	2.03	2.03	2.03

Source: S&P Capital IQ. Standard template. Financial Sources.